Marking Requirements for Repackaged Prescription Medication Imported into the United States
Published Sep 10, 2024
Summary
CBP issued a ruling (HQ H283420) and fact sheet clarifying country of origin marking requirements for repackaged prescription medication imported into the United States, requiring such medications sold to retail customers to be marked with country of origin.
Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.
CSMS 62097992 · full bulletinRelated bulletins
Consumer Product Safety Commission (CPSC) Implementation Guide and Partner Government Agency (PGA) Flag Enforcement Table Documents Updated on CBP.gov
Jul 28, 2026
Harmonized System Update (HSU) 2617
Jul 27, 2026
Harmonized System Update (HSU) 2616
Jul 23, 2026
Notice from the U.S. Fish and Wildlife Service regarding Final Rule Amending 50 CFR Part 10 Shellfish Definition and Updated Tariff Flagging
Jul 15, 2026
Harmonized System Update (HSU) 2615
Jul 14, 2026